Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret Ashcroft

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Pigment Cell & Melanoma Research|August 3, 2010
TRP-ing off the p53 apoptotic switchAfshan Ahmed, Margaret Ashcroft
Pigment Cell & Melanoma Research|September 16, 2010
TRP-ing off the p53 apoptotic switchAfshan Ahmed, Margaret Ashcroft
Biochemical Society Transactions|February 18, 2021
CHCHD4 (MIA40) and the mitochondrial disulfide relay systemHasan Al-Habib, Margaret Ashcroft
Expert Reviews in Molecular Medicine|April 16, 2005
Targeting the molecular basis for tumour hypoxiaVeronica A Carroll, Margaret Ashcroft
Cancer Research|January 18, 2008
Regulation of angiogenic factors by HDM2 in renal cell carcinomaVeronica A Carroll, Margaret Ashcroft
Frontiers in Cell and Developmental Biology|November 8, 2021
The Contextual Essentiality of Mitochondrial Genes in CancerLuke W Thomas, Margaret Ashcroft
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|February 28, 2004
Hypoxia-inducible factor-1 and oncogenic signallingJulia I Bárdos, Margaret Ashcroft
Breast Cancer Research : BCR|December 19, 2003
Akt2: a role in breast cancer metastasisNoan-Minh Chau, Margaret Ashcroft
Cancer Research|June 17, 2006
Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathwayVeronica A Carroll, Margaret Ashcroft
Cellular and Molecular Life Sciences : CMLS|February 16, 2019
Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondriaLuke W Thomas, Margaret Ashcroft
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Pigment Cell & Melanoma Research|August 3, 2010
TRP-ing off the p53 apoptotic switchAfshan Ahmed, Margaret Ashcroft
Pigment Cell & Melanoma Research|September 16, 2010
TRP-ing off the p53 apoptotic switchAfshan Ahmed, Margaret Ashcroft
Biochemical Society Transactions|February 18, 2021
CHCHD4 (MIA40) and the mitochondrial disulfide relay systemHasan Al-Habib, Margaret Ashcroft
Expert Reviews in Molecular Medicine|April 16, 2005
Targeting the molecular basis for tumour hypoxiaVeronica A Carroll, Margaret Ashcroft
Cancer Research|January 18, 2008
Regulation of angiogenic factors by HDM2 in renal cell carcinomaVeronica A Carroll, Margaret Ashcroft
Frontiers in Cell and Developmental Biology|November 8, 2021
The Contextual Essentiality of Mitochondrial Genes in CancerLuke W Thomas, Margaret Ashcroft
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|February 28, 2004
Hypoxia-inducible factor-1 and oncogenic signallingJulia I Bárdos, Margaret Ashcroft
Breast Cancer Research : BCR|December 19, 2003
Akt2: a role in breast cancer metastasisNoan-Minh Chau, Margaret Ashcroft
Cancer Research|June 17, 2006
Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathwayVeronica A Carroll, Margaret Ashcroft
Cellular and Molecular Life Sciences : CMLS|February 16, 2019
Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondriaLuke W Thomas, Margaret Ashcroft
Pageof 6